CTKB PEER ANALYSIS

Cytek Biosciences Inc — metric-by-metric comparison with peers and the industry median

CTKBCytek Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

CTKBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CTKB	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
P/E	—	—	20.73●	122.41	596.83	24.27	26.82
P/B	1.81	-76.08●	2.50	13.36	1.08	4.32	2.50
EV/EBITDA	—	—	9.94●	25.46	10.93	15.20	15.54
P/S	2.91	249.46	2.10	7.66	1.18●	3.55	2.69

Financial Health
Metric	CTKB	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Current Ratio	4.69	6.57●	2.57	2.25	3.58	2.46	3.28
Debt/Equity	11.1%	-22.6%●	62.9%	35.0%	1.0%	22.1%	44.7%
NetDebt/EBITDA	10.20	0.71	1.72	0.42	-1.64●	0.42	0.82

Profitability
Metric	CTKB	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Net Margin	-36.2%	-3,684.6%	10.1%	6.3%	0.2%	14.6%●	-5.7%
ROE	-20.9%	—	12.1%	12.9%	0.2%	18.1%●	-8.6%
ROA	-15.9%	-264.3%	6.1%	8.0%	0.2%	12.4%●	-6.4%
EBITDA Margin	-10.8%	-818.8%	25.6%	30.6%●	9.4%	24.0%	5.2%

Growth + Dividend
Metric	CTKB	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Rev. Growth	3.6%	-26.0%	—	39.1%●	6.5%	2.0%	7.4%
NI Growth	—	—	—	—	-62.9%	-6.8%●	16.7%
Div. Yield	—	—	3.5%	0.0%	1.1%	3.6%●	1.1%
Payout	—	—	52.8%	0.0%	656.3%	81.5%	39.0%

Valuation
Metric	CTKB	CERS	CLPT	PACB	TCMD	VMD	Ind. Median
P/E	—	—	—	—	35.42	32.98●	26.82
P/B	1.81●	9.43	28.23	214.56	3.30	3.41	2.50
EV/EBITDA	—	549.34	—	—	15.88	9.31●	15.54
P/S	2.91	2.86	13.10	3.17	2.09	1.71●	2.69

Financial Health
Metric	CTKB	CERS	CLPT	PACB	TCMD	VMD	Ind. Median
Current Ratio	4.69	1.63	5.79●	5.65	4.24	1.22	3.28
Debt/Equity	11.1%	144.1%	337.5%	29,729.0%	7.0%●	8.6%	44.7%
NetDebt/EBITDA	10.20	14.23	-1.18	-4.01●	-1.44	0.05	0.82

Profitability
Metric	CTKB	CERS	CLPT	PACB	TCMD	VMD	Ind. Median
Net Margin	-36.2%	-4.3%	-71.6%	-80.3%	5.9%●	5.2%	-5.7%
ROE	-20.9%	-15.5%	-149.7%	-273.6%	9.6%	10.7%●	-8.6%
ROA	-15.9%	-4.4%	-47.1%	-15.6%	7.3%	7.9%●	-6.4%
EBITDA Margin	-10.8%	0.5%	-58.2%	-66.6%	12.1%	18.5%●	5.2%

Growth + Dividend
Metric	CTKB	CERS	CLPT	PACB	TCMD	VMD	Ind. Median
Rev. Growth	3.6%	20.3%	26.0%●	5.0%	17.2%	23.1%	7.4%
NI Growth	—	—	—	—	25.3%●	21.2%	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CTKB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.